Dr. Kaiming Ye is Professor and Chair of Biomedical Engineering and Director of the Center of Biomanufacturing for Regenerative Medicine at Binghamton University (BU), SUNY. He is one of the world-leading scientists in advanced biomanufacturing. He is fellow of AIMBE, Fellow of the Biomedical Engineering Society, and senior member of IEEE. He was Chair of the Council of Chairs of Biomedical Engineering and a member of NIH/NIDDK Rebuilding Kidney Consortium’s Advisory Committee. Dr. Ye pioneered islet organoid development from human pluripotent stem cells (HPSCs). His group is the first one that demonstrated the feasibility of generating functional human islets from HPSCs. Dr. Ye is one of the pioneers who designed fluorescence resonance energy transfer nanosensors for continuous glucose monitoring. Dr. Ye’s recent work on cancer immunotherapy led to the development of a new cancer immunotherapeutic vaccine. Dr. Ye has published one book, more than 100 high impact peer-reviewed research articles, book chapters, proceedings, and reports. He has chaired and co-chaired more than 15 international and national conferences and delivered more than 50 keynote/plenary/invited speeches in international and national conferences and graduate seminars in more than 60 universities. He has contributed significantly to national policy-making in science and engineering. During his tenure at the NSF, he directed a biomedical engineering program. He was a member of the Interagency Workgroup for Neuroscience, Interagency Modeling and Analysis Workgroup, and Multiagency Tissue Engineering and Regenerative Medicine Workgroup.